Smoking kills (alcoholics)! shouldn't we do something about it?

Alcohol and Alcoholism

Volumn 42, Issue 3, 2007, Pages 167-173

  Littleton, John ^a,d   Barron, Susan ^b   Prendergast, Mark ^b   Nixon, Sara Jo ^c  

^a University of Kentucky   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d Kentucky Tobacco Research and Development Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACAMPROSATE; AGMATINE; ALCOHOL; AMFEBUTAMONE; DISULFIRAM; DOPAMINE; ENDORPHIN; GLUTAMATE RECEPTOR; GLUTAMIC ACID; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NALTREXONE; NICOTINE; NICOTINE PATCH; NICOTINIC RECEPTOR; OPIATE ANTAGONIST; OPIATE RECEPTOR;

ALCOHOL ABSTINENCE; ALCOHOL WITHDRAWAL; ALCOHOLISM; ASSOCIATION; CENTRAL NERVOUS SYSTEM DEPRESSION; CIGARETTE SMOKING; COGNITIVE DEFECT; CONDITIONING; DOPAMINE RELEASE; DRUG TARGETING; HIGH RISK POPULATION; HUMAN; HYPERALGESIA; INCIDENCE; MAJOR DEPRESSION; MORTALITY; NEUROTRANSMISSION; NONHUMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; REINFORCEMENT; RELAPSE; REVIEW; RISK FACTOR; SMOKING CESSATION; TOBACCO DEPENDENCE; VENTRAL TEGMENTUM;

ALCOHOLISM; COMORBIDITY; ETHANOL; HUMANS; NICOTINE; RECEPTORS, GLUTAMATE; RECEPTORS, NICOTINIC; RECEPTORS, OPIOID; REINFORCEMENT (PSYCHOLOGY); SMOKING; TOBACCO USE DISORDER;

ANIMALIA;

EID: 34447505083     PISSN: 07350414     EISSN: 14643502     Source Type: Journal    
DOI: 10.1093/alcalc/agm019     Document Type: Review

References (93)

1. Adriani, W., Spijker, S., Deroche-Gamonet, V. et al. (2003) Evidence for enhanced neurobehavioral vulnerability to nicotine during periadolescence in rats. Journal of Neuroscience 23, 4712-4716.
2. Almeida, L. E., Pereira, E. F., Camara, A. L. et al. (2004) Sensitivity of neuronal nicotinic acetylcholine receptors to the opiate antagonists naltrexone and naloxone: Receptor blockade and up-regulation. Bioorganic and Medicinal Chemistry Letters 14 1879-1887.
3. Benowitz, N. L. (2003) Cigarette smoking and cardiovascular disease: pathophysiology and implications for treatment. Progress in Cardiovascular Diseases 46, 91-111.
4. Biala, G. and Kotlinska, J. (1999) Blockade of the acquisition of ethanol-induced conditioned place preference by N-methyl-D-aspartate receptor antagonists. Alcohol and Alcoholism 34, 175-182.
5. Bickel, W., DeGrandpre, R. J. and Higgins, S. T. (1995) The behavioral economics of concurrent drug reinforcers: A review and reanalysis of drug self-administration research. Psychopharmacology 118, 250-259.
6. Bisaga, A., Popik, P., Bespalov, A. Y. et al. (2000) Therapeutic potential of NMDA receptor antagonists in the treatment of alcohol and substance use disorders. Expert Opinion on Investigatory Drugs 9, 2233-2248.
7. Blalock, J. A., Robinson, J. D., Wetter, D. W. et al. (2006) Relationship of DSM-IV-based depressive disorders to smoking cessation and smoking reduction in pregnant smokers. American Journal of Addiction 15, 268-277.
8. Bleich, S., Carl, M., Bayerlein, K. et al. (2005) Evidence of increased homocysteine levels in alcoholism: The Franconian alcoholism research studies (FARS). Alcoholism: Clinical and Experimental Research 29, 334-336.
9. Bobo, J. K. (1992) Nicotine dependence and alcoholism epidemiology and treatment. Journal of Psychoactive Drugs 24, 123-129.
10. Booker, T. K. and Collins, A. C. (1997) Long term ethanol treatment elicits changes in nicotinic binding in only a few brain regions. Alcohol 14, 131-140.
11. Brauer, L. H., Behm, F. M. and Westman, E. C. (1999) Naltrexone blockade of nicotine effects in cigarette smokers. Psychopharmacology 143, 339-346.
12. Brioni, J. D., O'Neill, A. B., Kim, D. J. et al. (1993) Nicotinic receptor agornists exhibit anxiolytic-like effects on the elevated plus maze tests. European Journal of Pharmacology 238, 1-8.
13. Brody, A. L., Mandelkern, M. A., London, E. D. et al. (2006) Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors. Archives of General Psychiatry 63, 907-915.
14. Burgess, E. S., Brown, R. A., Kahler, C. W. et al. (2002) Patterns of change in depressive symptoms during smoking cessation: Who's at risk for relapse? Journal of Consulting and Clinical Psychology 70 356-361.
15. Byars, J. A., Frost-Pineda, K., Jacobs, W. S. et al. (2005) Naltrexone augments the effects of nicotine replacement therapy in female smokers. Journal of Addiction Disorders 24, 49-60.
16. Ceballos, N. A., Tivis, R., Lawton-Craddock, A. et al. (2005) Visual-spatial attention in alcoholics and illicit stimulant abusers: effects of nicotine replacement. Progress in Neuro-Psychopharmacology and Biological Psychiatry 29, 97-107.
17. Ceballos, N. A., Tivis, R., Lawton-Craddock, A. et al. (2006) Nicotine and cognitive efficiency in alcoholics and illicit stimulant abusers: Implications of smoking cessation for substance users in treatment. Substance use and Misuse 41, 265-281.
18. Cole, J. C., Littleton, J. M. and Little, H. J. (2000) Acamprosate, but not naltrexone, inhibits conditioned abstinence behaviour associated with repeated ethanol administration and exposure to a plus-maze. Psychopharmacology 147, 403-411.
19. Covernton, P. J. and Connolly, J. G. (1997) Differential modulation of rat neuronal nicotinic receptor subtypes by acute application of ethanol. British Journal of Pharmacology 122, 1661-1668.
20. Currie, S. R., Hodgins, D. C., el-Guebaly N. et al. (2001) Influence of depression and gender on smoking expectancies and temptations in alcoholics in early recovery. Journal of Substance Abuse 13, 443-458.
21. De Witte, P., Littleton, J., Parot, P. et al. (2005) Neuroprotective and abstinence-promoting effects of acamprosate: elucidating the mechanism of action. CNS Drugs 19, 517-537.
22. DiFranza, J. R. and Guerrera, M. P. (1990) Alcoholism and smoking. Journal of Studies on Alcoholism 51, 130-135.
23. Epstein, A. M. and King, A. C. (2004) Naltrexone attenuates acute cigarette smoking behavior. Pharmacology, Biochemistry and Behavior 77, 29-37.
24. Field, M., Mogg, K. and Bradley, B. P. (2005) Alcohol increases cognitive biases for smoking cues in smokers. Psychopharmacology 180, 63-72.
25. Fudala, P. J. and Iwamoto, E. T. (1986) Further studies on nicotine-induced conditioned place preference in the rat. Pharmacology, Biochemistry and Behavior 25, 1041-1049.
26. Glassman, A. H., Covey, L. S. and Stetner, S. R. (2001) Smoking cessation and the course of major depression: A follow-up study. Lancet 357, 1930-1932.
27. Grabus, S. D., Martin, B. R. and Imad Damaj, M. (2005) Nicotine physical dependence in the mouse: Involvement of the alpha7 nicotinic receptor subtype. European Journal of Pharmacology 515, 90-93.
28. Grant, B. F., Hasin, D. S., Chou, P. S. et al. (2004) Nicotine dependence and psychiatric disorders in the United States. Archives of General Psychiatry 61, 1107-1115.
29. Gulliver, S. B., Rohsenow, D. J., Colby, S. M. et al. (1995) Interrelationship of smoking and alcohol dependence, use and urges to use. Journal of Studies on Alcoholism 56, 202-206.
30. Hayford, K. E., Patten, C. A., Rummans, T. A. et al. (1999) Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism. British Journal of Psychiatry 174, 173-178.
31. Hellstrom-Lindahl, E. and Nordberg, A. (2002) Smoking during pregnancy: a way to transfer addiction to the next generation? Respiration 69, 289-293.
32. Hertling, I., Ramskogler, K., Dvorak, A. et al. (2005) Craving and other characteristics of the comorbidity of alcohol and nicotine dependence. European Journal of Psychiatry 20, 442-450.
33. Hill, S. Y., Lowers, L., Locke-Wellman, J. et al. (2000) Maternal smoking and drinking during pregnancy and the risk for child and adolescent psychiatric disorders. Journal of Studies on Alcoholism 61, 661-668.
34. Hillemacher, T., Bayerlein, K., Wilhelm, J. et al. (2006) Nicotine dependence is associated with compulsive alcohol craving. Addiction 101, 892-897.
35. Hoffman, P. L. (2003) NMDA receptors in alcoholism. International Review of Neurobiology 56, 35-82.
36. Horn, K., Gao, X., Williams, J. et al. (2000) Conjoint smoking and drinking: A case for dual-substance intervention among young emergency department patients. Academic Emergency Medicine 7, 1126-1134.
37. Hughes, J. R., Rose, G. L. and Callas, P. W. (2000) Nicotine is more reinforcing in smokers with a past history of alcoholism than in smokers without this history. Alcoholism: Clinical and Experimental Research 24, 1633-1638.
38. Hurt, R. D., Offord, K. P., Croghan, I. T. et al. (1996) Mortality following inpatient addictions treatment: Role of tobacco use in a community-based cohort. Journal of the American Medical Association 275, 1097-1103.
39. Hurt, R. D. and Patten, C. A. (2003) Treatment of tobacco dependence in alcoholics. Recent Developments in Alcoholism 16, 335-359.
40. Hutchison, K. E., Monti, P. M., Rohsenow, D. J. et al. (1999) Effects of naltrexone with nicotine replacement on smoking cue reactivity: Preliminary results. Psychopharmacology 142, 139-143.
41. Iwamoto, E. T. (1990) Nicotine conditions place preferences after intracerebral administration in rats. Psychopharmacology 100 251-257.
42. Jacques, P. F., Bostom, A. G., Wilson, P. W. et al. (2001) Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. American Journal of Clinical Nutrition 73, 613-621.
43. John, U., Meyer, C., Rumpf, H. J. et al. (2003) Probabilities of alcohol high-risk drinking, abuse or dependence estimated on grounds of tobacco smoking and nicotine dependence. Addiction 98, 805-814.
44. Junghanns, K., Veltrup, C. and Wetterling, T. (2000) Craving shift in chronic alcoholics. European Addiction Research 6, 64-70.
45. King, A., de Wit, H., Riley, R. C. et al. (2006) Efficacy of naltrexone in smoking cessation: A preliminary study and an examination of sex differences. Nicotine and Tobacco Research 8, 671-682.
46. Kosowski, A. R., Cebers, G., Cebere, A. et al. (2004) Nicotine-induced dopamine release in the nucleus accumbens is inhibited by the novel AMPA antagonist ZK200775 and the NMDA antagonist CGP39551. Psychopharmacology 175, 114-132.
47. Krishnan-Sarin, S., Meandzija, B. and O'Malley, S. (2003) Naltrexone and nicotine patch smoking cessation: A preliminary study. Nicotine and Tobacco Research 5, 851-857.
48. Lin C. H., Lee, C. C., Huang, Y. C. et al. (2005) Activation of group II metabotropic glutamate receptors induces depotentiation in amygdala slices and reduces fear-potentiated startle in rats. Learning and Memory 12, 130-137.
49. Littleton, J. and Zieglgansberger, W. (2003) Pharmacological mechanisms of naltrexone and acamprosate in the prevention of relapse in alcohol dependence. American Journal of Addiction 12 (Suppl. 1), S3-11.
50. Liu, Q., Li, Z., Ding, J. H. et al. (2006) Iptakalim inhibits nicotine-induced enhancement of extracellular dopamine and glutamate levels in nucleus accumbens of rats. Brain Research 1085, 138-143.
51. Lominac, K. D., Kapasova, Z., Hannun, R. A. et al. (2006) Behavioral and neurochemical interactions between Group 1 mGluR antagonists and ethanol: Potential insight into their anti-addictive properties. Drug and Alcohol Dependence 85, 142-156.
52. Lovinger, D. M. (1996) Interactions between ethanol and agents that act on the NMDA-type glutamate receptor. Alcoholism: Clinical and Experimental Research 20, 187A-191A.
53. Marino, M. J. and Conn, P. J. (2002) Direct and indirect modulation of the N-methyl-D-aspartate receptor. Current Drug Targets. CNS and Neurological Disorders 1, 1-16.
54. Marks, J. L., Hill, E. M., Pomerleau, C. S. et al. (1997) Nicotine dependence and withdrawal in alcoholic and nonalcoholic ever-smokers. Journal of Substance Abuse and Treatment 14, 521-527.
55. Marszalec, W., Aistrup, G. L. and Narahashi, T. (1999) Ethanol-nicotine interactions at alpha-bungarotoxin-insensitive nicotinic acetylcholine receptors in rat cortical neurons. Alcoholism: Clinical and Experimental Research 23, 439-445.
56. Mattson, S. N. and Riley, E. P. (1998) A review of the neurobehavioral deficits in children with fetal alcohol syndrome or prenatal exposure to alcohol. Alcoholism: Clinical and Experimental Research 22, 279-294.
57. McGeehan, A. J. and Olive, M. F. (2003) The anti-relapse compound acamprosate inhibits the development of a conditioned place preference to ethanol and cocaine but not morphine. British Journal of Pharmacology 138, 9-12.
58. McKinney, A. and Coyle, K. (2006) Alcohol hangover effects on measures of affect the morning after a normal night's drinking. Alcohol 41, 54-60.
59. Mello, N. K., Mendelson, J. H., Sellers, M. L. et al. (1980) Effects of alcohol and marijuana on tobacco smoking. Clinical Pharmacology and Therapeutics 27, 202-209.
60. Meyerhoff, D. J., Tizabi, Y., Staley, J. K. et al. (2006) Smoking comorbidity in alcoholism: Neurobiological and neurocognitive consequences. Alcoholism: Clinical and Experimental Research 30 253-264.
61. Miller, N. S. and Gold, M. S. (1998) Comorbid cigarette and alcohol addiction: Epidemiology and treatment. Journal of Addictive Diseases 17, 55-66.
62. Modesto-Lowe, V. and Kranzler, H. R. (1999) Diagnosis and treatment of alcohol-dependent patients with comorbid psychiatric disorders. Alcohol Research and Health 23, 144-149.
63. Novak, A., Burgess, E. S., Clark, M. et al. (2003) Anxiety sensitivity, self-reported motives for alcohol and nicotine use, and level of consumption. Journal of Anxiety Disorders 17, 165-180.
64. Novy, P., Hughes, J. R. and Callas, P. (2001) A comparison of recovering alcoholic and nonalcoholic smokers. Drug and Alcohol Dependence 65, 17-23.
65. Obot, I. S., Wagner, F. A. and Anthony, J. C. (2001) Early onset and recent drug use among children of parents with alcohol problems: Data from a national epidemiological survey. Drug and Alcohol Dependence 65, 1-8.
66. Office of Applied Studies. (2004) Results from the 2003 National Survey on Drug Use and Health: National findings (DHHS Publication No. SMA 04-3964, NSDUH Series H-25). Substance Use During Pregnancy: 2002 and 2003 Update Rockville, MD: Substance Abuse and Mental Health Services Administration.
67. Olive, M. F., Koenig, H. N., Nannini, M. A. et al. (2001) Stimulation of endorphin neurotransmission in the nucleus accumbens by ethanol, cocaine, and amphetamine. Journal of Neuroscience 21 184.
68. O'Malley, S. S., Cooney, J. L. and Krishnan-Sarin, S. et al. (2006) A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation. Archives of Internal Medicine 166, 667-674.
69. O'Malley, P. M., Johnston, L. D. and Bachman, J. G. (1998) Alcohol use among adolescents. Alcohol Health and Research World 22, 85-93.
70. Owens, J. C., Balogh, S. A., McClure-Begley, T. D. et al. (2003) Alpha 4 beta 2 nicotinic acetylcholine receptors modulate the effects of ethanol and nicotine on the acoustic startle response. Alcoholism: Clinical and Experimental Research 27, 1867-1875.
71. Paavola, M., Vartiainen, E. and Haukkala, A. (2004) Smoking, alcohol use, and physical activity: A 13-year longitudinal study ranging from adolescence into adulthood. Journal of Adolescent Health 35, 238-244.
72. Papp, M., Gruca, P. and Willner, P. (2002) Selective blockade of drug-induced place preference conditioning by ACPC, a functional NMDA-receptor antagonist. Neuropsychopharmacology 27, 727-743.
73. Pauly, J. R., Marks, M. J., Robinson, S. F. et al. (1996) Chronic nicotine and mecamylaine treatment increase brain nicotinic receptor binding without changing alpha 4 or beta 2 mRNA levels. Journal of Pharmacology and Experimental Therapeutics 278, 361-369.
74. Pisani A., Gubellini P., Bonsi, P. et al. (2001) Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons. Neuroscience 106 579-587.
75. Rogers, D. T., Barron, S. and Littleton, J. M. (2004) Neonatal ethanol exposure produces a hyperealgesia that extends into adolescence, and is associated with increased analgesic and rewarding properties of nicotine in rats. Psychopharmacology 171, 204-211.
76. Rohsenow, D. J., Monti, P. M., Colby, S. M. et al. (1997) Effects of alcohol cues on smoking urges and topography among alcoholic men. Alcoholism: Clinical and Experimental Research 21, 101-107.
77. Rohsenow, D. J., Monti, P. M., Colby, S. M. et al. (2003) Naltrexone treatment for alcoholics: Effect on cigarette smoking rates. Nicotine and Tobacco Research 5, 231-236.
78. Rukstalis, M., Jepson, C., Strasser, A. et al. (2005) Naltrexone reduces the relative reinforcing value of nicotine in a cigarette smoking choice paradigm. Psychopharmacology 180, 41-48.
79. Sasco, A. J., Secretan, M. B. and Straif, K. (2004) Tobacco smoking and cancer: A brief review of recent epidemiological evidence. Lung Cancer 45 (Suppl. 2), S3-S9.
80. Saulskaya, N. B. and Soloviova, N. A. (2004) Tetrodotoxin-dependent glutamate release in the rat nucleus accumbens during concurrent presentation of appetitive and conditioned aversive stimuli. Journal of Neuroscience Methods 140, 15-21.
81. Schaefer, G. J. and Michael, R. P. (1992) Interactions between alcohol and nicotine on intracranial self-stimulation and locomotor activity in rats. Drug and Alcohol Dependence 30, 37-47.
82. Shoaib, M., Stolerman, I. P. and Kumar, R. C. (1994) Nicotine-induced place preferences following prior nicotine exposure in rats. Psychopharmacology 113, 445-452.
83. Simons, C. T., Cuellar, J. M., Moore, J. A. et al. (2005) Nicotinic receptor involvement in antinociception induced by exposure to cigarette smoke. Neuroscience Letters 389, 71-76.
84. Sullivan, M. A. and Rudnik-Levin, F. (2001) Attention deficit/ hyperactivity disorder and substance abuse: Diagnostic and therapeutic considerations. Annals of the New York Academy of Sciences 931 251-270.
85. Sutherland, G., Stapleton, J. A., Russell, M. A. et al. (1995) Naltrexone, smoking behavior and cigarette withdrawal. Psychopharmacology 120, 418-425.
86. Tiffany, S. T. (1990) A cognitive model of drug urges and drug-use behavior: The role of automatic and non-automatic processes. Psychological Review 97, 147-168.
87. Tonstad, S. (2002) Use of sustained release bupropion in specific patient populations for smoking cessation. Drugs 62 (Suppl. 2), 37-43.
88. Trujillol, K. A. and Akil, H. (1995) Excitatory amino acids and drugs of abuse: A role for N-methyl-D-aspartate receptors in drug tolerance, sensitization and physical dependence. Drug and Alcohol Dependence 38, 139-154.
89. Tsai, G. (1998) Glutamatergic neurotransmission in alcoholism. Journal of Biomedical Sciences 5, 309-320.
90. Upadhyaya, H. P. (2006) Do patients with ADHD have a harder time quitting cigarettes? Journal of the American Academy of Child and Adolescent Psychiatry 45, 891.
91. Weiss, F. and Koob, G. F. (2001) Drug addiction: Functional neurotoxicity of the brain reward systems. Neurotoxicological Research 3, 145-156.
92. Wong, G. Y., Wolter, T. D. and Croghan, G. A. (1999) A randomized trial of naltrexone for smoking cessation. Addiction 94, 1227-1237.
93. Yates, W. R., Cadoret, R. J., Troughton, E. P. et al. (1998) Effect of fetal alcohol exposure on adult symptoms of nicotine, alcohol and drug dependence. Alcoholism: Clinical and Experimental Research 22, 914-920.